O	0	9	Increased	Increase	VBN	B-NP
O	10	20	expression	expression	NN	I-NP
O	21	23	of	of	IN	B-PP
O	24	32	specific	specific	JJ	B-NP
O	33	40	protein	protein	NN	I-NP
O	41	49	tyrosine	tyrosine	NN	I-NP
O	50	62	phosphatases	phosphatas	NNS	I-NP
O	63	65	in	in	IN	B-PP
O	66	71	human	human	JJ	B-NP
B-Cell	72	78	breast	breast	NN	I-NP
I-Cell	79	89	epithelial	epithelial	JJ	I-NP
I-Cell	90	95	cells	cell	NNS	I-NP
O	96	110	neoplastically	neoplastically	RB	B-VP
O	111	122	transformed	transform	VBN	I-VP
O	123	125	by	by	IN	B-PP
O	126	129	the	the	DT	B-NP
O	130	133	neu	neu	NN	I-NP
O	134	142	oncogene	oncogene	NN	I-NP
O	142	143	.	.	.	O

O	145	152	Protein	Protein	NN	B-NP
O	153	161	tyrosine	tyrosine	NN	I-NP
O	162	177	phosphorylation	phosphorylation	NN	I-NP
O	177	178	/	/	SYM	B-NP
O	178	195	dephosphorylation	dephosphorylation	NN	I-NP
O	196	198	is	be	VBZ	B-VP
O	199	200	a	a	DT	B-NP
O	201	212	fundamental	fundamental	JJ	I-NP
O	213	222	mechanism	mechanism	NN	I-NP
O	223	225	in	in	IN	B-PP
O	226	229	the	the	DT	B-NP
O	230	240	regulation	regulation	NN	I-NP
O	241	243	of	of	IN	B-PP
B-Cell	244	248	cell	cell	NN	B-NP
O	249	262	proliferation	proliferation	NN	I-NP
O	263	266	and	and	CC	O
B-Cancer	267	277	neoplastic	neoplastic	JJ	B-NP
O	278	292	transformation	transformation	NN	I-NP
O	292	293	;	;	:	O
O	294	298	this	this	DT	B-NP
O	299	308	metabolic	metabolic	JJ	I-NP
O	309	316	process	process	NN	I-NP
O	317	319	is	be	VBZ	B-VP
O	320	329	modulated	modulate	VBN	I-VP
O	330	332	by	by	IN	B-PP
O	333	336	the	the	DT	B-NP
O	337	345	opposing	oppose	VBG	I-NP
O	346	356	activities	activity	NNS	I-NP
O	357	359	of	of	IN	B-PP
O	360	367	protein	protein	NN	B-NP
O	368	376	tyrosine	tyrosine	NN	I-NP
O	377	384	kinases	kinase	NNS	I-NP
O	385	388	and	and	CC	O
O	389	396	protein	protein	NN	B-NP
O	397	405	tyrosine	tyrosine	NN	I-NP
O	406	418	phosphatases	phosphatas	NNS	I-NP
O	419	420	(	(	(	O
O	420	427	PTPases	PTPas	NNS	B-NP
O	427	428	)	)	)	O
O	428	429	.	.	.	O

O	430	435	While	While	IN	B-SBAR
O	436	439	the	the	DT	B-NP
O	440	444	role	role	NN	I-NP
O	445	447	of	of	IN	B-PP
O	448	455	protein	protein	NN	B-NP
O	456	464	tyrosine	tyrosine	NN	I-NP
O	465	472	kinases	kinase	NNS	I-NP
O	473	476	has	have	VBZ	B-VP
O	477	481	been	be	VBN	I-VP
O	482	490	examined	examine	VBN	I-VP
O	491	502	extensively	extensively	RB	B-ADVP
O	503	505	in	in	IN	B-PP
O	506	511	human	human	JJ	B-NP
B-Organism_subdivision	512	518	breast	breast	NN	I-NP
O	519	532	tumorigenesis	tumorigenesis	NN	I-NP
O	532	533	,	,	,	O
O	534	537	the	the	DT	B-NP
O	538	542	role	role	NN	I-NP
O	543	545	of	of	IN	B-PP
O	546	553	PTPases	PTPas	NNS	B-NP
O	554	556	in	in	IN	B-PP
O	557	561	this	this	DT	B-NP
O	562	569	process	process	NN	I-NP
O	570	572	is	be	VBZ	B-VP
O	573	582	virtually	virtually	RB	B-ADJP
O	583	590	unknown	unknown	JJ	I-ADJP
O	590	591	.	.	.	O

O	592	594	To	To	TO	B-VP
O	595	602	address	address	VB	I-VP
O	603	607	this	this	DT	B-NP
O	608	613	issue	issue	NN	I-NP
O	613	614	,	,	,	O
O	615	617	an	an	DT	B-NP
O	618	627	activated	activate	VBN	I-NP
O	628	631	neu	neu	NN	I-NP
O	632	640	oncogene	oncogene	NN	I-NP
O	641	644	was	be	VBD	B-VP
O	645	655	introduced	introduce	VBN	I-VP
O	656	660	into	into	IN	B-PP
O	661	663	an	an	DT	B-NP
O	664	676	immortalized	immortalize	VBN	I-NP
O	677	691	nontumorigenic	nontumorigenic	JJ	I-NP
O	692	697	human	human	JJ	I-NP
B-Cell	698	704	breast	breast	NN	I-NP
I-Cell	705	715	epithelial	epithelial	JJ	I-NP
I-Cell	716	720	cell	cell	NN	I-NP
I-Cell	721	725	line	line	NN	I-NP
O	726	727	(	(	(	O
B-Cell	727	732	184B5	184B5	NN	B-NP
O	732	733	)	)	)	O
O	733	734	.	.	.	O

O	735	739	This	This	DT	B-NP
O	740	748	resulted	result	VBD	B-VP
O	749	751	in	in	IN	B-PP
O	752	753	a	a	DT	B-NP
O	754	765	substantial	substantial	JJ	I-NP
O	766	774	increase	increase	NN	I-NP
O	775	777	in	in	IN	B-PP
O	778	785	P185neu	P185neu	NN	B-NP
O	786	796	expression	expression	NN	I-NP
O	796	797	,	,	,	O
O	798	803	which	which	WDT	B-NP
O	804	807	led	lead	VBD	B-VP
O	808	810	to	to	TO	B-PP
O	811	814	the	the	DT	B-NP
O	815	824	formation	formation	NN	I-NP
O	825	827	of	of	IN	B-PP
O	828	841	progressively	progressively	RB	B-VP
O	842	849	growing	grow	VBG	I-VP
B-Cancer	850	860	carcinomas	carcinoma	NNS	B-NP
O	861	866	after	after	IN	B-SBAR
O	867	871	such	such	JJ	B-NP
B-Cell	872	877	cells	cell	NNS	I-NP
O	878	882	were	be	VBD	B-VP
O	883	893	inoculated	inoculate	VBN	I-VP
O	894	898	into	into	IN	B-PP
O	899	906	athymic	athymic	JJ	B-NP
O	907	911	nude	nude	JJ	I-NP
O	912	916	mice	mouse	NNS	I-NP
O	916	917	.	.	.	O

O	918	929	Importantly	Importantly	RB	B-ADVP
O	929	930	,	,	,	O
O	931	932	a	a	DT	B-NP
O	933	941	striking	striking	JJ	I-NP
O	942	950	increase	increase	NN	I-NP
O	951	953	in	in	IN	B-PP
O	954	957	the	the	DT	B-NP
O	958	968	expression	expression	NN	I-NP
O	969	971	of	of	IN	B-PP
O	972	980	specific	specific	JJ	B-NP
O	981	988	PTPases	PTPas	NNS	I-NP
O	988	989	,	,	,	O
O	990	993	LAR	LAR	NN	B-NP
O	994	997	and	and	CC	I-NP
O	998	1003	PTP1B	PTP1B	NN	I-NP
O	1003	1004	,	,	,	O
O	1005	1008	was	be	VBD	B-VP
O	1009	1017	observed	observe	VBN	I-VP
O	1018	1020	in	in	IN	B-PP
O	1021	1022	3	3	CD	B-NP
O	1023	1036	independently	independently	RB	I-NP
O	1037	1040	neu	neu	NN	I-NP
O	1041	1052	transformed	transform	VBN	I-NP
B-Cell	1053	1057	cell	cell	NN	I-NP
I-Cell	1058	1063	lines	line	NNS	I-NP
O	1064	1067	and	and	CC	O
O	1068	1073	their	their	PRP$	B-NP
O	1074	1081	derived	derive	VBN	I-NP
B-Cancer	1082	1088	tumors	tumor	NNS	I-NP
O	1088	1089	.	.	.	O

O	1090	1094	This	This	DT	B-NP
O	1095	1104	elevation	elevation	NN	I-NP
O	1105	1108	was	be	VBD	B-VP
O	1109	1117	verified	verify	VBN	I-VP
O	1118	1120	at	at	IN	B-PP
O	1121	1125	both	both	CC	O
O	1126	1129	the	the	DT	B-NP
O	1130	1134	mRNA	mRNA	NN	I-NP
O	1135	1138	and	and	CC	I-NP
O	1139	1146	protein	protein	NN	I-NP
O	1147	1153	levels	level	NNS	I-NP
O	1153	1154	.	.	.	O

O	1155	1157	TC	TC	NN	B-NP
O	1157	1158	-	-	HYPH	I-NP
O	1158	1161	PTP	PTP	NN	I-NP
O	1162	1168	PTPase	PTPase	NN	I-NP
O	1169	1179	expression	expression	NN	I-NP
O	1180	1183	was	be	VBD	B-VP
O	1184	1188	only	only	RB	B-VP
O	1189	1197	slightly	slightly	RB	I-VP
O	1198	1207	increased	increase	VBN	I-VP
O	1208	1210	in	in	IN	B-PP
O	1211	1216	these	these	DT	B-NP
O	1217	1220	neu	neu	NN	I-NP
O	1221	1232	transformed	transform	VBN	I-NP
B-Cell	1233	1238	cells	cell	NNS	I-NP
O	1238	1239	,	,	,	O
O	1240	1243	and	and	CC	O
O	1244	1246	no	no	DT	B-NP
O	1247	1257	expression	expression	NN	I-NP
O	1258	1260	of	of	IN	B-PP
O	1261	1265	CD45	CD45	NN	B-NP
O	1266	1272	PTPase	PTPase	NN	I-NP
O	1273	1276	was	be	VBD	B-VP
O	1277	1285	observed	observe	VBN	I-VP
O	1285	1286	.	.	.	O

O	1287	1290	The	The	DT	B-NP
O	1291	1296	level	level	NN	I-NP
O	1297	1299	of	of	IN	B-PP
O	1300	1303	neu	neu	NN	B-NP
O	1304	1314	expression	expression	NN	I-NP
O	1314	1315	,	,	,	O
O	1316	1318	as	as	RB	B-CONJP
O	1319	1323	well	well	RB	I-CONJP
O	1324	1326	as	as	IN	I-CONJP
O	1327	1330	the	the	DT	B-NP
O	1331	1343	differential	differential	JJ	I-NP
O	1344	1354	expression	expression	NN	I-NP
O	1355	1362	between	between	IN	B-PP
O	1363	1370	P185neu	P185neu	NN	B-NP
O	1371	1374	and	and	CC	I-NP
O	1375	1378	LAR	LAR	NN	I-NP
O	1378	1379	/	/	SYM	B-NP
O	1379	1384	PTP1B	PTP1B	NN	I-NP
O	1384	1385	,	,	,	O
O	1386	1394	directly	directly	RB	B-VP
O	1395	1405	correlated	correlate	VBD	I-VP
O	1406	1410	with	with	IN	B-PP
O	1411	1425	tumorigenicity	tumorigenicity	NN	B-NP
O	1425	1426	.	.	.	O

O	1427	1438	Furthermore	Furthermore	RB	B-ADVP
O	1438	1439	,	,	,	O
O	1440	1443	rat	rat	NN	B-NP
B-Cancer	1444	1451	mammary	mammary	JJ	I-NP
I-Cancer	1452	1462	carcinomas	carcinoma	NNS	I-NP
O	1463	1467	with	with	IN	B-PP
O	1468	1476	elevated	elevate	VBN	B-NP
O	1477	1480	neu	neu	NN	I-NP
O	1481	1491	expression	expression	NN	I-NP
O	1492	1493	(	(	(	O
O	1493	1496	neu	neu	NN	B-NP
O	1496	1497	-	-	HYPH	O
O	1497	1504	induced	induce	VBN	B-VP
O	1504	1505	)	)	)	O
O	1506	1510	also	also	RB	B-ADVP
O	1511	1514	had	have	VBD	B-VP
O	1515	1522	sharply	sharply	RB	I-VP
O	1523	1531	elevated	elevate	VBN	I-VP
O	1532	1535	LAR	LAR	NN	B-NP
O	1535	1536	-	-	HYPH	O
O	1536	1542	PTPase	PTPase	NN	B-NP
O	1543	1553	expression	expression	NN	I-NP
O	1554	1558	when	when	WRB	B-ADVP
O	1559	1567	compared	compare	VBN	B-VP
O	1568	1570	to	to	TO	B-PP
O	1571	1574	rat	rat	NN	B-NP
B-Cancer	1575	1582	mammary	mammary	JJ	I-NP
I-Cancer	1583	1593	carcinomas	carcinoma	NNS	I-NP
O	1594	1598	with	with	IN	B-PP
O	1599	1605	little	little	JJ	B-NP
O	1606	1608	or	or	CC	I-NP
O	1609	1611	no	no	DT	I-NP
O	1612	1615	neu	neu	NN	I-NP
O	1616	1626	expression	expression	NN	I-NP
O	1627	1628	(	(	(	O
O	1628	1629	7	7	CD	B-NP
O	1629	1630	,	,	,	O
O	1630	1632	12	12	CD	B-NP
O	1632	1633	-	-	HYPH	I-NP
O	1633	1655	dimethylbenzanthracene	dimethylbenzanthracene	NN	I-NP
O	1656	1663	induced	induce	VBN	B-VP
O	1663	1664	)	)	)	O
O	1664	1665	;	;	:	O
O	1666	1669	the	the	DT	B-NP
O	1670	1675	level	level	NN	I-NP
O	1676	1678	of	of	IN	B-PP
O	1679	1689	expression	expression	NN	B-NP
O	1690	1692	of	of	IN	B-PP
O	1693	1696	LAR	LAR	NN	B-NP
O	1697	1703	PTPase	PTPase	NN	I-NP
O	1704	1707	was	be	VBD	B-VP
O	1708	1716	directly	directly	RB	I-VP
O	1717	1727	correlated	correlate	VBN	I-VP
O	1728	1732	with	with	IN	B-PP
O	1733	1736	the	the	DT	B-NP
O	1737	1742	level	level	NN	I-NP
O	1743	1745	of	of	IN	B-PP
O	1746	1749	neu	neu	NN	B-NP
O	1750	1760	expression	expression	NN	I-NP
O	1760	1761	.	.	.	O

O	1762	1766	Thus	Thus	RB	B-ADVP
O	1766	1767	,	,	,	O
O	1768	1771	our	our	PRP$	B-NP
O	1772	1779	results	result	NNS	I-NP
O	1780	1787	provide	provide	VBP	B-VP
O	1788	1791	the	the	DT	B-NP
O	1792	1797	first	first	JJ	I-NP
O	1798	1806	evidence	evidence	NN	I-NP
O	1807	1811	that	that	IN	B-NP
O	1811	1812	,	,	,	O
O	1813	1815	in	in	IN	B-PP
O	1816	1821	human	human	JJ	B-NP
B-Cell	1822	1828	breast	breast	NN	I-NP
I-Cell	1829	1838	carcinoma	carcinoma	NN	I-NP
I-Cell	1839	1844	cells	cell	NNS	I-NP
O	1845	1848	and	and	CC	B-PP
O	1849	1851	in	in	IN	B-PP
O	1852	1855	rat	rat	NN	B-NP
B-Cancer	1856	1863	mammary	mammary	JJ	I-NP
I-Cancer	1864	1874	carcinomas	carcinoma	NNS	I-NP
O	1875	1879	that	that	WDT	B-NP
O	1880	1884	have	have	VBP	B-VP
O	1885	1887	an	an	DT	B-NP
O	1888	1895	induced	induce	VBN	I-NP
O	1896	1904	increase	increase	NN	I-NP
O	1905	1907	in	in	IN	B-PP
O	1908	1911	neu	neu	NN	B-NP
O	1912	1922	expression	expression	NN	I-NP
O	1922	1923	,	,	,	O
O	1924	1925	a	a	DT	B-NP
O	1926	1936	consistent	consistent	JJ	I-NP
O	1937	1940	and	and	CC	I-NP
O	1941	1952	substantial	substantial	JJ	I-NP
O	1953	1961	increase	increase	NN	I-NP
O	1962	1964	in	in	IN	B-PP
O	1965	1968	the	the	DT	B-NP
O	1969	1979	expression	expression	NN	I-NP
O	1980	1982	of	of	IN	B-PP
O	1983	1991	specific	specific	JJ	B-NP
O	1992	1999	PTPases	PTPas	NNS	I-NP
O	2000	2006	occurs	occur	VBZ	B-VP
O	2006	2007	.	.	.	O

O	2008	2011	The	The	DT	B-NP
O	2012	2024	relationship	relationship	NN	I-NP
O	2025	2032	between	between	IN	B-PP
O	2033	2040	P185neu	P185neu	NN	B-NP
O	2040	2041	-	-	HYPH	I-NP
O	2041	2048	protein	protein	NN	I-NP
O	2049	2057	tyrosine	tyrosine	NN	I-NP
O	2058	2064	kinase	kinase	NN	I-NP
O	2065	2075	expression	expression	NN	I-NP
O	2076	2079	and	and	CC	O
O	2080	2088	specific	specific	JJ	B-NP
O	2089	2095	PTPase	PTPase	NN	I-NP
O	2096	2106	expression	expression	NN	I-NP
O	2107	2110	may	may	MD	B-VP
O	2111	2115	play	play	VB	I-VP
O	2116	2117	a	a	DT	B-NP
O	2118	2126	critical	critical	JJ	I-NP
O	2127	2131	role	role	NN	I-NP
O	2132	2134	in	in	IN	B-PP
O	2135	2140	human	human	JJ	B-NP
B-Organism_subdivision	2141	2147	breast	breast	NN	I-NP
O	2148	2161	tumorigenesis	tumorigenesis	NN	I-NP
O	2161	2162	.	.	.	O

